- Home
- Publications
- Publication Search
- Publication Details
Title
Biomarkers in mesothelioma
Authors
Keywords
-
Journal
ANNALS OF CLINICAL BIOCHEMISTRY
Volume 55, Issue 1, Pages 49-58
Publisher
SAGE Publications
Online
2018-04-12
DOI
10.1177/0004563217741145
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Pleural biopsies in undiagnosed pleural effusions; Abrams vs image-guided vs thoracoscopic biopsies
- (2016) Anna C. Bibby et al. CURRENT OPINION IN PULMONARY MEDICINE
- A Novel Clinical Prediction Model for Prognosis in Malignant Pleural Mesothelioma Using Decision Tree Analysis
- (2016) Fraser J.H. Brims et al. Journal of Thoracic Oncology
- Bevacizumab for newly diagnosed pleural mesothelioma in the Mesothelioma Avastin Cisplatin Pemetrexed Study (MAPS): a randomised, controlled, open-label, phase 3 trial
- (2016) Gérard Zalcman et al. LANCET
- Prophylactic radiotherapy for the prevention of procedure-tract metastases after surgical and large-bore pleural procedures in malignant pleural mesothelioma (SMART): a multicentre, open-label, phase 3, randomised controlled trial
- (2016) Amelia O Clive et al. LANCET ONCOLOGY
- Protocol for PIT: a phase III trial of prophylactic irradiation of tracts in patients with malignant pleural mesothelioma following invasive chest wall intervention
- (2016) N Bayman et al. BMJ Open
- Diagnostic and Prognostic Biomarkers in the Rational Assessment of Mesothelioma (DIAPHRAGM) study: protocol of a prospective, multicentre, observational study
- (2016) Selina Tsim et al. BMJ Open
- ENOX2-based early detection (ONCOblot) of asbestos-induced malignant mesothelioma 4–10 years in advance of clinical symptoms
- (2016) D. James Morré et al. Clinical Proteomics
- The South West Area Mesothelioma and Pemetrexed trial: a multicentre prospective observational study evaluating novel markers of chemotherapy response and prognostication
- (2015) C E Hooper et al. BRITISH JOURNAL OF CANCER
- The effect of chemotherapy on health-related quality of life in mesothelioma: results from the SWAMP trial
- (2015) D T Arnold et al. BRITISH JOURNAL OF CANCER
- Effect of Opioids vs NSAIDs and Larger vs Smaller Chest Tube Size on Pain Control and Pleurodesis Efficacy Among Patients With Malignant Pleural Effusion
- (2015) Najib M. Rahman et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Demographics, management and survival of patients with malignant pleural mesothelioma in the National Lung Cancer Audit in England and Wales
- (2015) P. Beckett et al. LUNG CANCER
- Malignant Pleural Mesothelioma: Visual Assessment by Using Pleural Pointillism at Diffusion-weighted MR Imaging
- (2015) Johan Coolen et al. RADIOLOGY
- Phase 1 study of the antimesothelin immunotoxin SS1P in combination with pemetrexed and cisplatin for front-line therapy of pleural mesothelioma and correlation of tumor response with serum mesothelin, megakaryocyte potentiating factor, and cancer antigen
- (2014) Raffit Hassan et al. CANCER
- Efficacy and cost of video-assisted thoracoscopic partial pleurectomy versus talc pleurodesis in patients with malignant pleural mesothelioma (MesoVATS): an open-label, randomised, controlled trial
- (2014) Robert C Rintoul et al. LANCET
- Combination of MiR-103a-3p and Mesothelin Improves the Biomarker Performance of Malignant Mesothelioma Diagnosis
- (2014) Daniel G. Weber et al. PLoS One
- Comparison of fibulin-3 and mesothelin as markers in malignant mesothelioma
- (2014) Jenette Creaney et al. THORAX
- Diagnostic values of soluble mesothelin-related peptides for malignant pleural mesothelioma: updated meta-analysis
- (2014) Ai Cui et al. BMJ Open
- Diagnostic Accuracy of 18F-FDG-PET and PET/CT in the Differential Diagnosis between Malignant and Benign Pleural Lesions
- (2013) Giorgio Treglia et al. ACADEMIC RADIOLOGY
- Molecular pathogenesis of malignant mesothelioma
- (2013) Y. Sekido CARCINOGENESIS
- Soluble Mesothelin-Related Peptides Levels in Patients with Malignant Mesothelioma
- (2013) Alenka Franko et al. DISEASE MARKERS
- A phase II clinical trial of the Vascular Disrupting Agent BNC105P as second line chemotherapy for advanced Malignant Pleural Mesothelioma
- (2013) Anna K. Nowak et al. LUNG CANCER
- Pleural effusion hyaluronic acid as a prognostic marker in pleural malignant mesothelioma
- (2013) Jenette Creaney et al. LUNG CANCER
- Multicenter, Double-Blind, Placebo-Controlled, Randomized Phase II Trial of Gemcitabine/Cisplatin Plus Bevacizumab or Placebo in Patients With Malignant Mesothelioma
- (2012) Hedy L. Kindler et al. JOURNAL OF CLINICAL ONCOLOGY
- Fibulin-3 as a Blood and Effusion Biomarker for Pleural Mesothelioma
- (2012) Harvey I. Pass et al. NEW ENGLAND JOURNAL OF MEDICINE
- Early Detection of Malignant Pleural Mesothelioma in Asbestos-Exposed Individuals with a Noninvasive Proteomics-Based Surveillance Tool
- (2012) Rachel M. Ostroff et al. PLoS One
- Inhibition of Stabilin-2 elevates circulating hyaluronic acid levels and prevents tumor metastasis
- (2012) Y. Hirose et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- The Effect of Clinical Covariates on the Diagnostic and Prognostic Value of Soluble Mesothelin and Megakaryocyte Potentiating Factor
- (2011) Kevin Hollevoet et al. CHEST
- Soluble Mesothelin, Megakaryocyte Potentiating Factor, and Osteopontin as Markers of Patient Response and Outcome in Mesothelioma
- (2011) Kevin Hollevoet et al. Journal of Thoracic Oncology
- Extra-pleural pneumonectomy versus no extra-pleural pneumonectomy for patients with malignant pleural mesothelioma: clinical outcomes of the Mesothelioma and Radical Surgery (MARS) randomised feasibility study
- (2011) Tom Treasure et al. LANCET ONCOLOGY
- Plasma versus serum levels of osteopontin and mesothelin in patients with malignant mesothelioma—Which is best?
- (2011) Jenette Creaney et al. LUNG CANCER
- Retreatment with pemetrexed-based chemotherapy in patients with malignant pleural mesothelioma
- (2011) Giovanni L. Ceresoli et al. LUNG CANCER
- Diffusion-Weighted MRI of Malignant Pleural Mesothelioma: Preliminary Assessment of Apparent Diffusion Coefficient in Histologic Subtypes
- (2010) Ritu R. Gill et al. AMERICAN JOURNAL OF ROENTGENOLOGY
- Serum Mesothelin for Early Detection of Asbestos-Induced Cancer Malignant Mesothelioma
- (2010) J. Creaney et al. CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION
- Serum Soluble Mesothelin Concentrations in Malignant Pleural Mesothelioma: Relationship to Tumor Volume, Clinical Stage and Changes in Tumor Burden
- (2010) J. Creaney et al. CLINICAL CANCER RESEARCH
- Soluble Mesothelin-Related Peptide and Osteopontin As Markers of Response in Malignant Mesothelioma
- (2010) Paul Wheatley-Price et al. JOURNAL OF CLINICAL ONCOLOGY
- Pemetrexed Plus Cisplatin or Pemetrexed Plus Carboplatin for Chemonaïve Patients with Malignant Pleural Mesothelioma: Results of the International Expanded Access Program
- (2010) Armando Santoro et al. Journal of Thoracic Oncology
- Clinical Significance of Serum Vascular Endothelial Growth Factor in Malignant Pleural Mesothelioma
- (2010) Akihiro Yasumitsu et al. Journal of Thoracic Oncology
- Kinetics of Soluble Mesothelin in Patients with Malignant Pleural Mesothelioma during Treatment
- (2009) Bogdan D. Grigoriu et al. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
- New Dual Monoclonal ELISA for Measuring Plasma Osteopontin as a Biomarker Associated with Survival in Prostate Cancer: Clinical Validation and Comparison of Multiple ELISAs
- (2009) P. H. Anborgh et al. CLINICAL CHEMISTRY
- Guidelines of the European Respiratory Society and the European Society of Thoracic Surgeons for the management of malignant pleural mesothelioma
- (2009) A. Scherpereel et al. EUROPEAN RESPIRATORY JOURNAL
- Fibulin-3 Is Uniquely Upregulated in Malignant Gliomas and Promotes Tumor Cell Motility and Invasion
- (2009) B. Hu et al. MOLECULAR CANCER RESEARCH
- Computed Tomography, Positron Emission Tomography, Positron Emission Tomography/Computed Tomography, and Magnetic Resonance Imaging for Staging of Limited Pleural Mesothelioma
- (2008) Christian Plathow et al. INVESTIGATIVE RADIOLOGY
- Phase III Trial of Pemetrexed Plus Best Supportive Care Compared With Best Supportive Care in Previously Treated Patients With Advanced Malignant Pleural Mesothelioma
- (2008) Jacek Jassem et al. JOURNAL OF CLINICAL ONCOLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started